Mitchell Steiner
Amministratore Delegato presso VERU INC.
Patrimonio netto: 9 M $ in data 30/04/2024
Profilo
Mitchell Shuster Steiner is the founder of GTx, Inc., which was founded in 1997.
He held the title of Vice Chairman, Chief Executive Officer & CSO from 2011 to 2012.
He is also the founder of Aspen Park Pharmaceuticals, Inc., which was founded in 2014.
He held the title of Vice Chairman, President & Chief Executive Officer from 2014 to 2016.
Currently, Dr. Steiner is the Chairman, President & Chief Executive Officer at Veru, Inc. since 2016.
He is also a Director at The Female Health Company (UK) Plc and Mezzion Pharma Co., Ltd.
In the past, Dr. Steiner worked as a Professor at the University of Tennessee from 1995 to 2004.
He was the President-Urology at OPKO Health, Inc. from 2014 to 2016.
He also served as an Assistant Professor at Vanderbilt University School of Medicine from 1993 to 1995.
Dr. Steiner received his undergraduate and doctorate degrees from Vanderbilt University.
He also obtained a doctorate degree from the University of Tennessee.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
VERU INC
4.84% | 24/05/2024 | 7 086 709 ( 4.84% ) | 9 M $ | 30/04/2024 |
Posizioni attive di Mitchell Steiner
| Società | Posizione | Inizio |
|---|---|---|
| VERU INC. | Amministratore Delegato | 31/10/2016 |
| MEZZION PHARMA CO.,LTD. | Direttore/Membro del Consiglio | - |
The Female Health Company (UK) Plc
 The Female Health Company (UK) Plc Miscellaneous ManufacturingProducer Manufacturing Founded in 1989, The Female Health Company (UK) Plc is a subsidiary of Veru, Inc. that manufactures and sells condoms. The company is based in London, UK. | Direttore/Membro del Consiglio | 21/11/2016 |
Precedenti posizioni note di Mitchell Steiner
| Società | Posizione | Fine |
|---|---|---|
Aspen Park Pharmaceuticals, Inc.
 Aspen Park Pharmaceuticals, Inc. Medical DistributorsDistribution Services Aspen Park Pharmaceuticals, Inc. operated as a therapeutics company that focused on the development of men’s health therapies for medical diseases and conditions. The company was founded by Harry Fisch and Mitchell Shuster Steiner in July 2014 and was headquartered in New York, NY. | Fondatore | 01/10/2016 |
| OPKO HEALTH, INC. | Corporate Officer/Principal | 01/01/2016 |
GTx, Inc.
 GTx, Inc. Pharmaceuticals: MajorHealth Technology GTx, Inc. is a a biopharmaceutical company, which engages in the discovery, development, and commercialization of small molecules for the treatment of muscle-related diseases and other serious medical conditions. It focuses on developing selective androgen receptor modulators and selective androgen receptor degrader for the treatment of breast cancer, stress urinary incontinence, Duchenne muscular dystrophy, and prostate cancer. The company was founded by Marc Steven Hanover and Mitchell Shuster Steiner on September 24, 1997 and is headquartered in Memphis, TN. | Amministratore Delegato | - |
| University of Tennessee | Corporate Officer/Principal | 01/01/2004 |
| Vanderbilt University School of Medicine | Corporate Officer/Principal | 01/01/1995 |
Formazione di Mitchell Steiner
| Vanderbilt University | Doctorate Degree |
| University of Tennessee | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| VERU INC. | Health Technology |
| OPKO HEALTH, INC. | Health Services |
| MEZZION PHARMA CO.,LTD. | Health Technology |
| Aziende private | 3 |
|---|---|
GTx, Inc.
GTx, Inc. Pharmaceuticals: MajorHealth Technology GTx, Inc. is a a biopharmaceutical company, which engages in the discovery, development, and commercialization of small molecules for the treatment of muscle-related diseases and other serious medical conditions. It focuses on developing selective androgen receptor modulators and selective androgen receptor degrader for the treatment of breast cancer, stress urinary incontinence, Duchenne muscular dystrophy, and prostate cancer. The company was founded by Marc Steven Hanover and Mitchell Shuster Steiner on September 24, 1997 and is headquartered in Memphis, TN. | Health Technology |
Aspen Park Pharmaceuticals, Inc.
Aspen Park Pharmaceuticals, Inc. Medical DistributorsDistribution Services Aspen Park Pharmaceuticals, Inc. operated as a therapeutics company that focused on the development of men’s health therapies for medical diseases and conditions. The company was founded by Harry Fisch and Mitchell Shuster Steiner in July 2014 and was headquartered in New York, NY. | Distribution Services |
The Female Health Company (UK) Plc
The Female Health Company (UK) Plc Miscellaneous ManufacturingProducer Manufacturing Founded in 1989, The Female Health Company (UK) Plc is a subsidiary of Veru, Inc. that manufactures and sells condoms. The company is based in London, UK. | Producer Manufacturing |
- Borsa valori
- Insiders
- Mitchell Steiner
